Osaic Holdings’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-120
Closed -$134 7694
2024
Q3
$134 Hold
120
﹤0.01% 7220
2024
Q2
$131 Sell
120
-1,003
-89% -$1.13K ﹤0.01% 7213
2024
Q1
$1.43K Hold
1,123
﹤0.01% 6591
2023
Q4
$1.56K Sell
1,123
-608
-35% -$806 ﹤0.01% 6617
2023
Q3
$2.42K Buy
1,731
+728
+73% +$1.1K ﹤0.01% 6564
2023
Q2
$1.84K Hold
1,003
﹤0.01% 6694
2023
Q1
$2.44K Buy
1,003
+275
+38% +$409 ﹤0.01% 6634
2022
Q4
$1K Hold
728
﹤0.01% 7001
2022
Q3
$2K Hold
728
﹤0.01% 6858
2022
Q2
$2K Sell
728
-197
-21% -$487 ﹤0.01% 6955
2022
Q1
$3K Sell
925
-52
-5% -$167 ﹤0.01% 6792
2021
Q4
$3K Hold
977
﹤0.01% 6927
2021
Q3
$4K Sell
977
-751
-43% -$2.5K ﹤0.01% 6668
2021
Q2
$5K Hold
1,728
﹤0.01% 6394
2021
Q1
$6K Sell
1,728
-1,189
-41% -$3.7K ﹤0.01% 6100
2020
Q4
$8K Sell
2,917
-4,609
-61% -$10K ﹤0.01% 5623
2020
Q3
$16K Buy
7,526
+4,500
+149% +$10.7K ﹤0.01% 5045
2020
Q2
$7K Hold
3,026
﹤0.01% 5348
2020
Q1
$8K Buy
+3,026
New +$7.43K ﹤0.01% 5153

Other funds holding ENZ

Osaic Holdings's ENZ Position: Q4 2024 in Review

Osaic Holdings sold out of Enzo Biochem, Inc. (ENZ) in Q4 2024, closing a stake of 120 shares — an estimated $134 sold.

Osaic Holdings first reported a position in ENZ in Q1 2020 and held it in 19 quarters. The position peaked at $16K in Q3 2020. 45 funds tracked by Wall St. Rank hold ENZ as of Q4 2024.

  • Osaic Holdings reported no remaining Enzo Biochem, Inc. position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 120 Enzo Biochem, Inc. shares in Q4 2024, an estimated $134.
  • Osaic Holdings first reported a position in Enzo Biochem, Inc. in Q1 2020 and held it in 19 quarters.
  • Osaic Holdings's Enzo Biochem, Inc. position peaked at $16K in Q3 2020.
  • 45 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.